Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.75    0.00 (0.00%)
Bid:
13.50
Ask:
14.00
Spread: 0.50 (3.704%)
Market Cap: £61.76m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Director/PDMR Shareholding

22 Jan 2009 17:00

RNS Number : 1210M
China Real Estate Opportunities PLC
22 January 2009
ย 

๏ปฟ

ย 

China Real Estate Opportunitiesย plc

China Real Estate Opportunitiesย plcย (theย "Company")ย (AIM: CREO) announces thatย followingย the FSA announcement on 9 January 2009 relating to DTR 3.1.2ย which clarified that issuers should disclose to the market details of security over shares in an issuer granted by directors and their connected persons, the followingย personsย have granted security over shares in the Company.

Ray Horney, the Chairman, has pledged 2,750,000 shares as part collateral for loans entered into on 6 July 2007ย and 18 January 2008.

Richard Barrett, a director,ย has pledged 3,064,189 shares as collateral for loansย enteredย into onย 21 Juneย 2007 and 18 December 2007.

Treasury Holdings, a significant shareholder of the Company which is owned as to 50ย perย cent. by Richard Barrett,ย has pledged 661,000 shares as collateral for a loan entered into onย 26ย Juneย 2007.

Rory Williams, a director,ย has pledged 80,000 shares as collateral forย aย loanย entered into onย 21 Juneย 2007.

Rob Tincknell, a director,ย has pledged 321,171ย shares as collateral for loansย entered into onย 21 Juneย 2007ย and 18 October 2007.

Contact:

China Real Estate Opportunitiesย plc

Ray Horney, Chairman

Tel: + 44 (0) 1273 775 225ย 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

Matrix Corporate Capital LLP

Paul Fincham

Tel: + 44 (0) 20 3206 7000

Davy

Des Carville

Tel: +ย 353 1 679 6363

Bankside Consultantsย 

Simon Rothschild,ย Oliver Wintersย 

Tel:ย +ย 44 (0) 20 7367 8888

Murray Consultantsย 

Ed Micheau

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
RDSILFERLLIFFIA
Date   Source Headline
4th Jun 20267:00 amRNSPosting of 2025 Annual Report and Notice of AGM
28th May 20262:35 pmRNSHolding(s) in Company
22nd May 202610:11 amRNSResult of Placing
22nd May 20267:02 amRNSProposed Placing to raise approximately £5.5m
22nd May 20267:01 amRNSFY25 Final Results
22nd May 20267:00 amRNSProposed Sale of 49% Interest in Creo Medical SL
7th May 20267:00 amRNS-RMicroBlate™ Fine commercial update
5th May 20267:00 amRNS-RSpydrBlade™ Flex used in novel BEAM procedures
30th Apr 20267:00 amRNS-RKOL presentations on Creo Core Products at DDW
29th Apr 20267:00 amRNS-RUK private hospital use Speedboat for cancer case
22nd Apr 20267:00 amRNSPositive Q1 trading update
16th Apr 20267:00 amRNSDisposal and outsourcing of manufacturing
24th Feb 20267:00 amRNSAppointment of Joint Corporate Broker
20th Jan 20267:00 amRNSFY25 Trading Update
14th Jan 20267:00 amRNSAward of Shares under Share Incentive Plan
27th Oct 20257:00 amRNSNotice of Capital Markets Day
7th Oct 202511:37 amRNSCapital Markets Day update
22nd Sep 20257:00 amRNSUnaudited results for the six months ended 30 June
12th Sep 20253:14 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSNotice of Results
12th Aug 20254:56 pmRNSDirector/PDMR Share Dealing
4th Aug 20257:00 amRNS-RSpeedboat® patient testimonial
24th Jul 20257:00 amRNSAward of Shares under SIP and Director Dealings
21st Jul 20257:00 amRNSH1’25 Trading Update
10th Jul 20257:00 amRNS-RMicroBlate™ Flex begins lung tumour clinical study
9th Jul 20259:41 amRNSPDMR Options Revision
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:08 amRNSResult of AGM
26th Jun 20257:00 amRNSAGM Statement and Directorate Changes
11th Jun 20257:00 amRNS-RU.S. FDA clearance for SpydrBlade™ Flex
2nd Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSPosting of AR&R and Notice of AGM
28th May 20257:00 amRNSUS Reimbursement milestone for Speedboat procedure
27th May 202512:48 pmRNSHolding(s) in Company
23rd May 20254:25 pmRNSHolding(s) in Company
22nd May 20257:00 amRNSDirectorate changes
19th May 20257:00 amRNSFinal Results
6th May 20257:00 amRNSNotice of investor presentations
15th Apr 20252:00 pmRNSNotice of Results
1st Apr 20259:34 amRNSHolding(s) in Company
31st Mar 202512:17 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSGrant of Options
20th Mar 20257:00 amRNS-RUK & EU Commercial launch of SpydrBlade™ Flex
6th Mar 20257:00 amRNSAppointment of Nominated Adviser and sole Broker
17th Feb 20257:00 amRNSFY24 Trading Update
12th Feb 202511:00 amRNSCompletion of sale of 51% interest in subsidiary
6th Feb 20259:00 amRNS-RFirst Welsh adopter of Speedboat® technology
3rd Feb 20253:00 pmRNSTotal Voting Rights
21st Jan 20257:00 amRNSAward of Shares under Share Incentive Plan
15th Jan 20257:00 amRNSFirst robotic-guided lung ablation cases commence

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.